Toxoplasmosis laboratory findings: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Toxoplasmosis}} | {{Toxoplasmosis}} | ||
{{CMG}} ; {{AE}} {{ADG}} | |||
==Laboratory Findings== | |||
{{CMG}} | ===Interpretation of Serological Tests=== | ||
==Laboratory Findings=====Interpretation of Serological Tests=== | |||
{{familytree/start}} | {{familytree/start}} | ||
{{familytree | | | | | | | A01 | | | | | | | | | | | | | | | | |A01=IgG/IgM(ideally performed in the first trimester}} | {{familytree | | | | | | | A01 | | | | | | | | | | | | | | | | |A01=IgG/IgM(ideally performed in the first trimester}} | ||
Revision as of 16:18, 25 May 2017
|
Toxoplasmosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxoplasmosis laboratory findings On the Web |
|
American Roentgen Ray Society Images of Toxoplasmosis laboratory findings |
|
Risk calculators and risk factors for Toxoplasmosis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Laboratory Findings
Interpretation of Serological Tests
| IgG/IgM(ideally performed in the first trimester | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Negative IgG and IgM | Positive IgG Negative IgM | Positive IgM Negative IgG | Positive IgG and IgM | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ❑ No serologic evidence of Toxoplasma infection ❑ Risk of congenital Toxoplasmosis only if the woman aquires infection during the pregnancy ❑ Counsel about the preventive measures for T.gondii | <18 weeks of gestation Infection aquired in the past and prior to the pregnancy ❑ Risk of infection is zero unless the patient is immunocompromised ≥18 weeks of gestation ❑ It is difficult to establish the timing of infection | Repeat IgG and IgM in 1 to 3weeks | Serum should be sent to reference laboratory for confirmatory testing ❑ If the confirmatory test is positive initiate treatment and if negative follow up for 12 months | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Follow up testing is indicated during gestation to detect seroconversion | ≤ 18 weeks of gestation ❑ No further action indicated >18 weeks of gestation ❑ Compare to previous serological tests and send samples to a reference laboratory to confirm the timing of infection | ❑ Negative IgG and Positive IgM ❑ Does not have clinical relevance[1] | ❑ Positive IgG and IgM ❑ Seroconverted and fetus is at risk ❑ Initiate treatment and consider PCR | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table adopted from Management of Toxoplasma gondii Infection during Pregnancy[2]
Microscopy
A: Toxoplasma gondii tachyzoites, stained with Giemsa, from a smear of peritoneal fluid obtained from a mouse inoculated with T. gondii. Tachyzoites are typically crescent shaped with a prominent, centrally placed nucleus.
B: Toxoplasma gondii cyst in brain tissue stained with hematoxylin and eosin (100×). C: Zoom of Image B, T. gondii cyst.
References
- ↑ Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K; et al. (1997). "False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test". J Clin Microbiol. 35 (1): 174–8. PMC 229533. PMID 8968902.
- ↑ Montoya, Jose G.; Remington, Jack S. (2008). "Clinical Practice: Management ofToxoplasma gondiiInfection during Pregnancy". Clinical Infectious Diseases. 47 (4): 554–566. doi:10.1086/590149. ISSN 1058-4838.